Select Category

Test to predict Rheumatoid Arthritis

Go Back

Posted on by

Test to predict Rheumatoid Arthritis

Researchers at Oxford University have now come up with a new test that can accurately predict a person’s chances of being diagnosed with rheumatoid arthritis, up to 16 years in advance. This important breakthrough can help people make crucial lifestyle choices and take preventive measures.

How it works

This new test aims to identify a specific immunodominant peptide in addition to the “usual” autoantibodies found in patients with RA. The peptide, an “extracellular protein,” is called citrullinated tenascin-C (cTNC) and is often found in higher levels in the joints of rheumatoid arthritis patients. This led the Oxford scientists to wonder if it was, in fact, the thing that activates autoimmune antibodies in individuals with RA, and the cause of — or a contributor to — a process called citrullination.

During inflammatory RA flares, proteins are altered through citrullination, which is believed to cause the body’s immune system to viciously attack itself.

Lead study researcher, Anja Schwenzer, Ph.D said, “we knew that tenascin-C is found at high levels in the joints of people with RA.” Her team worked to see if this tenascin-C protein could actually be citrullinated, thus serving as a target for the autoantibodies attacking the body during RA flare-ups.

Details of the study

The study looked at more than 2,000 patients. The blood test accurately diagnosed RA in about 50 percent of cases. Unlike some other tests, it also had a low rate of false positives.

“What is particularly exciting is that when we looked at samples taken from people before their arthritis began, we could see these antibodies to cTNC up to 16 years before the disease occurred” said Professor Kim Midwood of the Oxford University Kennedy Institute. “On average, the antibodies could be found 7 years before the disease appeared,”

Hope for preventing arthritis

This discovery may be crucial because most rheumatologists acknowledge the importance of early detection and early treatment in rheumatoid arthritis. The earlier RA is treated, the more effective treatments may be and the less disability and deformity may occur.

This blood test may allow doctors to monitor predisposed patients closely and help them get their disease under control the moment symptoms begin to appear. “Early diagnosis is key, with research showing that there’s often a narrow window of opportunity following the onset of symptoms for effective diagnosis and control of disease through treatment,” says Stephen Simpson, director of research at Arthritis Research UK, the organization that funded the study.

#RheumatoidArthritis #Arthritis #AutoimmuneDisease #BloodTest #PreventingArthritis

About Arthritis Center

This web site is run by an Arthritis Specialist based in Dubai, United Arab Emirates. On this site you will find news about the latest in arthritis, information about research results in the field, tips and information and diet and exercise, and much more.

More

Archives


Latest Blog

Using your genes to predict if you will respond to Rheumatoid arthritis therapy. (not available in Dubai, UAE at this time)

The ORBIT data “showed that patients who have seropositive rheumatoid arthritis are just as likely to respond to rituximab therapy when compared ...

Read More

Your nose can repair your knee arthritis? Not yet in Dubai!

Doctors might one day be able to harvest cells from patients’ noses to produce cartilage that can be transplanted into damaged knee joints, a sma...

Read More

Green tea to the rescue!

Green tea has always been hailed for its anti-inflammatory properties. But researchers at Washington State University (WSU) in Spokane have now ide...

Read More

This web site is run by an Arthritis Specialist based in Dubai, United Arab Emirates. On this site you will find news about the latest in arthritis, information about research results in the field, tips and information and diet and exercise, and much more.

More

Recent Comments